Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,442.86 +61.51 (+0.73%) Bitcoin USD
62,852.87 +1,472.65 (+2.40%) CMC Crypto 200
1,303.26 -54.75 (-4.03%)
Xeris Biopharma Holdings, Inc. (XERS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.8500 |
| Open | 1.8500 |
| Bid | 1.8600 x 400 |
| Ask | 1.8900 x 800 |
| Day's range | 1.7206 - 1.8900 |
| 52-week range | 1.4600 - 3.2600 |
| Volume | |
| Avg. volume | 1,846,200 |
| Market cap | 278.718M |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4500 |
| Earnings date | 06 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.58 |
Simply Wall St.Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations
Xeris Biopharma Holdings ( NASDAQ:XERS ) First Quarter 2024 Results Key Financial Results Revenue: US$40.6m (up 22...
- Thomson Reuters StreetEvents
Q1 2024 Xeris Biopharma Holdings Inc Earnings Call
Q1 2024 Xeris Biopharma Holdings Inc Earnings Call
ZacksXeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
Xeris Biopharma (XERS) delivered earnings and revenue surprises of -16.67% and 2.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.